Search research articles
Contact Us
Filters
Showing results (91-100 of 204) with videos related to
Page
of 21
Sort By:
The Pediatric Infectious Disease Journal
|
January 16, 2002
Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome
Tawanda Gumbo, Gerard Kadzirange, Jens Mielke, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2021
Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration
Tawanda Gumbo, Carleton M Sherman, Devyani Deshpande, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
November 28, 2012
Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection
Mamta K Jain, Jotam G Pasipanodya, Lara Alder, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
Devyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
Devyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease
Shashikant Srivastava, Jotam Pasipanodya, Carleton M Sherman, et al.
The Journal of Infectious Diseases
|
November 30, 2023
Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients
Devyani Deshpande, Gesham Magombedze, Gunavanthi D Boorgula, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2022
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 204) with videos related to
Sort By:
Page
of 21
The Pediatric Infectious Disease Journal
|
January 16, 2002
Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome
Tawanda Gumbo, Gerard Kadzirange, Jens Mielke, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2021
Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration
Tawanda Gumbo, Carleton M Sherman, Devyani Deshpande, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
November 28, 2012
Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection
Mamta K Jain, Jotam G Pasipanodya, Lara Alder, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
Devyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
Devyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease
Shashikant Srivastava, Jotam Pasipanodya, Carleton M Sherman, et al.
The Journal of Infectious Diseases
|
November 30, 2023
Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients
Devyani Deshpande, Gesham Magombedze, Gunavanthi D Boorgula, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2022
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, et al.
Page
of 21